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pos pos
Hence, we believe that these controversial issues require further dis-
haviors of Vδ1 and Vδ2 T cell subsets in response to lifelong stress
and claimed that Vδ2pos T cells are not affected by aging and Human Cy-
tomegalovirus (HCMV) infection. While we agree that these two γδ T
cell subsets diverge both in phenotype/function and in tissue distribu-
tion, we are somewhat surprised that authors did not take into account
the several previously published and contradictory experimental evi-
dence in regards to senescence of Vδ2pos T cells [2,3]. These latter studies
reported that HCMV infection not only induces a clonal expansion of a
distinct Vγ9neg/Vδ2pos T cell subset, but also determines a concomitant
adaptive differentiation from CD27high naïve cells to CD27low/neg
terminal-effectors. However, Weili Xu et al. argued that the expression
and kinetics of both CD27 and CD45RA surface markers do not change
and follow the homeostatic changes of Vδ2pos T cells. This statement
goes in the opposite direction to previously reported ﬁndings as the
CD27/CD45RA phenotype has been shown to mark the maturation
and differentiation (TNaïve, TCentral-Memory, Teffector-Memory and TEffectory-
Memory RA) of Vδ2pos T cells. Indeed, the different surface expression of
both CD27 and CD45 parallel the progressive decrease of telomere
length, the proliferative capacity as well as the different effector-
functions and resistance to death of Vδ2+ T cells in response to antigens
and homeostatic cytokines [4,5].☆ Rebuttal to “Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence” by
Weili Xu et al
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